ACT Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

ACT Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$23K	Sell
2022 Q2	$34K	Hold
2022 Q1	$42K	Buy
2021 Q4	$70K	Sell
2021 Q3	$235K	Hold
2021 Q2	$287K	Buy